Metoclopramide 50mg Tablet Franchise in Ahmedabad

Gastroprokinetic & Anti-Emetic Therapy Supplier in Mumbai

Metoclide 50 Tablet Distributor in Delhi

Nausea & Vomiting Relief Tablet Franchise Opportunity in Bangalore

Gastrointestinal Disorder Tablet Stockist in Hyderabad
Metoclopramide 50mg Export & Manufacturing in Chandigarh

Home/Products /metoclopramide-50mg-tablet

Metoclide 50 Tablet

Composition : Metoclopramide (50mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Metoclide 50 Tablet contains Metoclopramide 50mg, a potent gastroprokinetic and anti-emetic agent indicated for the management of severe nausea, vomiting, delayed gastric emptying, and gastrointestinal motility disorders. It helps in improving gastric transit, reducing discomfort, and alleviating persistent digestive symptoms.

Metoclopramide works by antagonizing dopamine receptors in the chemoreceptor trigger zone and enhancing cholinergic activity in the gastrointestinal tract. This dual mechanism ensures effective relief from nausea, vomiting, and delayed gastric emptying.

For distributors and healthcare suppliers, Metoclide 50 Tablet is a high-demand gastrointestinal therapy product, commonly prescribed in hospitals, gastroenterology clinics, and outpatient departments. Its strong demand across acute care and chronic management ensures consistent market turnover.

Adding Metoclide 50 Tablet to your digestive and anti-emetic therapy segment creates strong opportunities in pharmacies, hospitals, gastroenterology centers, export markets, and third-party manufacturing. Its proven clinical efficacy, rapid relief profile, and prescriber confidence make it a valuable addition to pharmaceutical distribution portfolios.

Read More

About the Product

Metoclide 50 Tablet contains Metoclopramide 50mg, a potent gastroprokinetic and anti-emetic agent indicated for the management of severe nausea, vomiting, delayed gastric emptying, and gastrointestinal motility disorders. It helps in improving gastric transit, reducing discomfort, and alleviating persistent digestive symptoms.

Metoclopramide works by antagonizing dopamine receptors in the chemoreceptor trigger zone and enhancing cholinergic activity in the gastrointestinal tract. This dual mechanism ensures effective relief from nausea, vomiting, and delayed gastric emptying.

For distributors and healthcare suppliers, Metoclide 50 Tablet is a high-demand gastrointestinal therapy product, commonly prescribed in hospitals, gastroenterology clinics, and outpatient departments. Its strong demand across acute care and chronic management ensures consistent market turnover.

Adding Metoclide 50 Tablet to your digestive and anti-emetic therapy segment creates strong opportunities in pharmacies, hospitals, gastroenterology centers, export markets, and third-party manufacturing. Its proven clinical efficacy, rapid relief profile, and prescriber confidence make it a valuable addition to pharmaceutical distribution portfolios.

Common side effects may include drowsiness, fatigue, dizziness, headache, or mild gastrointestinal discomfort. Rare but serious side effects include extrapyramidal symptoms, restlessness, depression, or neuroleptic malignant syndrome. Patients should seek medical attention if severe neurological or allergic reactions occur.

Metoclide 50 Tablet is indicated for the management of delayed gastric emptying, gastroesophageal reflux disease (GERD), nausea and vomiting caused by chemotherapy, radiotherapy, surgery, or other gastrointestinal disorders.

Before taking Metoclide 50 Tablet, inform your doctor if you have a history of Parkinson’s disease, epilepsy, depression, or gastrointestinal obstruction. The tablet should be taken exactly as prescribed, and long-term use should be monitored by a healthcare professional to avoid potential side effects.

Store Metoclide 50 Tablet in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children and ensure the blister pack is intact. Do not use the tablet beyond its expiry date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation